Tools

LEADER 03413cam 22006374a 4500

001 ocm64688339;

003 OCoLC;

005 20141211193738.0;

008 060228s2006 ctu b 001 0 eng ;

010 a| 2006006514;

015 a| GBA6679812| bnb;

016 7 a| 1012711192| DNLM;

016 7 a| 0135268862| Uk;

019 a| 70881699;

020 a| 0300116640 (cloth : alk. paper);

020 a| 9780300116649;

029 1 a| NLMb| 101271119;

029 1 a| YDXCPb| 2413581;

029 1 a| IG#b| 0300116640;

035 a| (Sirsi) o64688339;

035 a| (OCoLC)64688339;

042 a| pcc;

043 a| n-us---;

049 a| EREE;

050 00 a| HD9666.6b| .E68 2006;

060 00 a| 2006 L-587;

060 10 a| QV 736b| E64o 2006;

082 00 a| 338.4/7615109732| 22;

100 1 a| Epstein, Richard Allen,d| 1943-=| ^A160549;

245 10 a| Overdose :b| how excessive government regulation stifles pharmaceutical innovation /c| Richard A. Epstein.;

300 a| xi, 283 pages ;c| 25 cm;

336 a| text2| rdacontent;

337 a| unmediated2| rdamedia;

338 a| volume2| rdacarrier;

500 a| "An Institute for Policy Innovation Book.";

504 a| Includes bibliographical references (p. 241-271) and index.;

505 0 a| Rising expectations-- and diminishing returns -- Property generally : externalities, coordination, and the public domain -- Intellectual property: the public domain and private rights -- Taming conflict of interests -- Federally sponsored research under Bayh-Dole -- The anticommons -- The single monopoly : current patent limitations -- Rate regulation : an unneeded swamp -- Patent purchases: a second swamp -- Socialization of R & D : the final swamp -- The steady expansion of FDA power -- FDA versus the individual : upstream or downstream decision making -- Drug withdrawal : too much, too soon -- Getting the drugs to market -- Deceptive marketing -- Tort preliminaries -- Product liability for prescription drugs : manufacturing and design cases -- The main event : misrepresentation, overpromotion, and duty to warn -- Conclusion : socialized medicines.;

610 10 a| United States.b| Food and Drug Administration.=| ^A1253;

650 0 a| Pharmaceutical industryx| Government policyz| United States.=| ^A3655;

650 0 a| Pharmaceutical industryz| United States.=| ^A638;

650 22 a| Government Regulationz| United States.=| ^A938505;

650 0 a| Political planningz| United States.=| ^A157276;

710 2 a| Yale University.b| Institute for Policy Innovation.=| ^A710804;

856 41 3| Table of contents onlyu| http://www.loc.gov/catdir/toc/ecip069/2006006514.html;

856 42 3| Contributor biographical informationu| http://www.loc.gov/catdir/enhancements/fy0643/2006006514-b.html;

856 42 3| Publisher descriptionu| http://www.loc.gov/catdir/enhancements/fy0643/2006006514-d.html;

994 a| C0b| ERE;

938 a| Baker & Taylorb| BKTYc| 30.00d| 30.00i| 0300116640n| 0006760116s| active;

938 a| YBP Library Servicesb| YANKn| 2413581;

938 a| Baker and Taylorb| BTCPn| 2006006514;

938 a| Ingramb| INGRn| 0300116640;

596 a| 1;

998 a| 1073859;

999 a| HD9666.6 .E68 2006w| LCc| 1i| 30372014043035d| 12/13/2010e| 9/24/2010l| JGESm| JOYNERn| 2p| $25.20q| 1r| Ys| Yt| JGESBKu| 12/19/2006x| BOOKz| JSTACKSo| .STAFF. 0;

Overdose : how excessive government regulation stifles pharmaceutical innovation / Richard A. Epstein.

Author/creator	Epstein, Richard Allen, 1943-
Other author	Yale University. Institute for Policy Innovation.
Format	Book
Publication Info	New Haven : Yale University Press, ©2006.
Description	xi, 283 pages ; 25 cm
Supplemental Content	Table of contents only
Supplemental Content	Contributor biographical information
Supplemental Content	Publisher description
Subjects	United States. Food and Drug Administration. Pharmaceutical industry--Government policy. --United States. Pharmaceutical industry--United States. Government Regulation--United States. Political planning--United States.

Contents	Rising expectations-- and diminishing returns -- Property generally : externalities, coordination, and the public domain -- Intellectual property: the public domain and private rights -- Taming conflict of interests -- Federally sponsored research under Bayh-Dole -- The anticommons -- The single monopoly : current patent limitations -- Rate regulation : an unneeded swamp -- Patent purchases: a second swamp -- Socialization of R & D : the final swamp -- The steady expansion of FDA power -- FDA versus the individual : upstream or downstream decision making -- Drug withdrawal : too much, too soon -- Getting the drugs to market -- Deceptive marketing -- Tort preliminaries -- Product liability for prescription drugs : manufacturing and design cases -- The main event : misrepresentation, overpromotion, and duty to warn -- Conclusion : socialized medicines.
General note	"An Institute for Policy Innovation Book."
Bibliography note	Includes bibliographical references (p. 241-271) and index.
LCCN	2006006514
ISBN	0300116640 (cloth : alk. paper)
ISBN	9780300116649

Availability

Library	Location	Call Number	Status	Item Actions
Joyner	General Stacks	HD9666.6 .E68 2006	✔ Available	Place Hold

Overdose : how excessive government regulation stifles pharmaceutical innovation / Richard A. Epstein.

Click here for more information about this title

Availability